V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010814 | 250008009 | 1.8 | 80 | Palliative (P) | 2013-07-30 | 2013-08-06 | CARBOPLATIN + VINORELBINE | 02 | N | 250032424 | CISPLATIN + GEMCITABINE |
| 250010817 | 250008012 | 1.52 | 75 | Palliative (P) | 2017-10-05 | 2017-10-05 | CVP R | 99 | N | 250032451 | GEMCARBO |
| 250010818 | 250008013 | 1.64 | 77 | Disease modification (D) | 2013-11-06 | 2013-11-06 | GEMCARBO | N | N | 250032451 | DOCETAXEL |
| 250010819 | 250008014 | 1.65 | 88.4 | Curative (C) | 2015-01-25 | 2015-01-25 | GEMCARBO | 02 | N | 250032455 | GEMCARBO |
| 250010820 | 250008015 | 1.56 | 60 | null | 2014-02-05 | 2014-02-05 | null | Y | N | 250032456 | DOCETAXEL |
| 250010821 | 250008018 | 1.58 | 67.8 | Curative (C) | 2015-01-14 | 2015-01-14 | CARBOPLATIN | 02 | N | 250032466 | CARBOPLATIN |
| 250010822 | 250008019 | 1.73 | 110 | Disease modification (D) | 2018-03-23 | 2018-03-27 | FLUOROURACIL + IRINOTECAN | 2 | N | 250032473 | VENETOCLAX |
| 250010823 | 250008021 | 1.52 | 76.8 | Disease modification (D) | 2017-10-16 | 2017-10-18 | CISPLATIN + VINORELBINE | N | N | 250032483 | CARBOPLATIN + VINORELBINE |
| 250010824 | 250008022 | 1.72 | 70.9 | Palliative (P) | 2017-09-28 | 2017-10-04 | IPM | 02 | Y | 250032486 | AZACITIDINE |
| 250010825 | 250008023 | 1.8 | 70.9 | Disease modification (D) | 2015-04-19 | 2015-04-23 | Venetoclax | N | N | 250032491 | GEMCARBO |
| 250010827 | 250008025 | 1.73 | 49 | Curative (C) | 2014-12-01 | 2014-12-26 | Abiraterone | 01 | N | 250032500 | PACLITAXEL |
| 250010828 | 250008026 | 1.61 | 74 | Palliative (P) | 2017-05-22 | 2017-05-29 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | null | 250032511 | CAPECITABINE + GEMCITABINE |
| 250010829 | 250008027 | 1.69 | 63.7 | Palliative (P) | 2016-09-27 | 2016-09-27 | Carboplatin AUC 6 - 10 | N | N | 250032516 | IPM |
| 250010830 | 250008028 | 1.71 | 60.9 | Adjuvant (A) | 2017-05-13 | 2017-05-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | 250032517 | GEMCARBO |
| 250010831 | 250008028 | null | null | Disease modification (D) | 2013-08-03 | 2013-08-03 | ANAGRELIDE | 02 | N | 250032517 | MELPHALAN |
| 250010832 | 250008029 | null | null | Disease modification (D) | 2018-03-09 | 2018-04-04 | Trastuzumab Subcutaneous | 02 | null | 250032532 | TEMOZOLOMIDE |
| 250010833 | 250008029 | 1.62 | 67 | Disease modification (D) | 2014-08-27 | 2014-08-27 | Pipobroman | 02 | N | 250032532 | BORTEZOMIB |
| 250010834 | 250008031 | 1.72 | 59.8 | null | 2014-06-13 | 2014-06-13 | Busulfan Oral | N | null | 250032537 | CISPLATIN + PACLITAXEL |
| 250010835 | 250008031 | 1.8 | 71 | Palliative (P) | 2018-06-08 | 2018-06-11 | Carboplatin + Vinorelbine Oral | 99 | N | 250032537 | AFLIBERCEPT + FU + IRINOTECAN |
| 250010836 | 250012612 | 1.78 | 85.7 | null | 2014-06-29 | 2014-06-30 | IPM | 2 | N | 250032546 | PEMETREXED |
| 250010837 | 250008032 | 1.67 | 89 | Palliative (P) | 2014-02-06 | 2014-04-20 | GEMCARBO | N | N | 250032557 | NOT MATCHED |
| 250010838 | 250010995 | null | 66 | Palliative (P) | null | 2015-02-21 | IPM | N | N | 250032558 | CARBOPLATIN |
| 250010839 | 250010996 | 1.85 | 65.4 | Disease modification (D) | 2017-09-15 | 2017-09-15 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 250032564 | DOCETAXEL |
| 250010840 | 250008036 | 1.65 | null | null | 2015-05-20 | 2015-06-03 | GemCarbo Days 1+8 | N | Y | 250032567 | PEMETREXED |
| 250010841 | 250010997 | 1.64 | 74 | Palliative (P) | 2015-08-17 | 2015-08-18 | GEMCARBO | 2 | N | 250032569 | CARBOPLATIN |
| 250010842 | 250008038 | null | null | Disease modification (D) | 2016-05-05 | 2016-05-14 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 250032571 | CARBOPLATIN + PACLITAXEL |
| 250010843 | 250008039 | 1.65 | 78 | null | 2014-07-03 | 2014-07-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 250032572 | GEMCARBO |
| 250010844 | 250010999 | 1.66 | null | null | 2017-12-28 | 2018-01-04 | Rituximab | 02 | null | 250032572 | GEMCARBO |
| 250010845 | 250008040 | 1.59 | 91.2 | Palliative (P) | 2014-04-20 | 2014-04-26 | Busulfan Oral | N | N | 250032601 | GEMCARBO |
| 250010846 | 250008042 | null | 80 | Disease modification (D) | 2017-03-09 | 2017-03-12 | Epirubicin | 2 | N | 250032606 | VENETOCLAX |
| 250010847 | 250008044 | null | null | Curative (C) | 2013-04-25 | 2013-05-05 | Cisplatin | N | N | 250032607 | BORTEZOMIB |
| 250010848 | 250008047 | 0 | 69.4 | Curative (C) | 2013-04-22 | 2013-04-29 | GemCarbo Days 1+8 | 02 | N | 250032609 | IPM |
| 250010849 | 250008047 | 1.78 | 64.5 | Curative (C) | 2013-07-18 | 2013-08-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250032609 | CARBOPLATIN + PACLITAXEL |
| 250010850 | 250008048 | null | null | Disease modification (D) | 2014-12-24 | 2015-01-02 | FLAG + Idarubicin | 02 | N | 250032613 | CISPLATIN + VINORELBINE |
| 250010851 | 250008049 | 1.63 | null | Palliative (P) | 2017-06-01 | 2017-06-01 | GEMCARBO | 02 | N | 250032645 | COMMAND TRIAL |
| 250010852 | 250008049 | 1.57 | 65.2 | Palliative (P) | 2016-07-22 | 2016-10-02 | Cytarabine Low Dose | N | N | 250032645 | GEMCARBO |
| 250010855 | 250008051 | 1.6 | 57 | null | 2014-03-02 | 2014-03-17 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | 250032670 | DA |
| 250010856 | 250008051 | null | 47.6 | Palliative (P) | 2016-06-21 | 2016-07-12 | THALIDOMIDE | 2 | N | 250032670 | PEMBROLIZUMAB |
| 250010857 | 250008052 | 1.72 | 67.4 | Disease modification (D) | 2016-06-10 | 2016-06-10 | DA 3+8 | N | N | 250032678 | PEMETREXED |
| 250010858 | 250008053 | null | null | null | 2016-01-16 | 2016-02-13 | COMMAND trial | 02 | null | 250032695 | IPM |
| 250010859 | 250008054 | null | 82 | Not known (9) | 2014-06-14 | 2014-07-06 | Pemetrexed | 02 | N | 250032699 | GEMCARBO |
| 250010860 | 250008054 | null | null | Palliative (P) | 2015-05-03 | 2015-05-24 | DA 3+8 | 02 | N | 250032699 | ABVD |
| 250010861 | 250008057 | null | 78.6 | Palliative (P) | 2017-08-08 | 2018-02-14 | FLAG + Idarubicin | N | N | 250032729 | GEMCARBO |
| 250010862 | 250008058 | 1.75 | 60.5 | Curative (C) | 2013-11-06 | 2013-12-09 | GemCarbo Days 1+8 | 2 | N | 250032744 | AML17 TRIAL |
| 250010863 | 250008058 | 1.7 | 94.8 | Palliative (P) | 2014-06-02 | 2014-12-29 | Cyclophosphamide Fludarabine (Oral) | N | N | 250032744 | PEMETREXED |
| 250010864 | 250008059 | 1.77 | 64.9 | Palliative (P) | 2017-04-17 | 2017-04-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250032755 | COMMAND TRIAL |
| 250010865 | 250008060 | null | 66.6 | Palliative (P) | 2014-08-29 | 2015-01-30 | Bortezomib +/- Dexamethasone | null | N | 250032761 | GEMCARBO |
| 250010866 | 250008060 | 1.63 | 81 | Palliative (P) | 2013-04-05 | 2013-04-05 | FBC Conditionining | N | N | 250032761 | IPM |
| 250010867 | 250012614 | 1.78 | 80.4 | Curative (C) | 2016-02-13 | 2016-02-20 | CETUXIMAB + OXALIPLATIN + MDG | null | null | 250032785 | PEMETREXED |
| 250010868 | 250008062 | 1.78 | 60.8 | Disease modification (D) | 2013-04-21 | 2015-02-18 | GEMCARBO | N | null | 250032798 | COMMAND TRIAL |